Airline stocks have done very well in the last few years, but these 3 have plenty of upside left.
Celgene Corp, Alkermes, GW Pharmaceuticals, Gilead Sciences, and Hospira should all be on investors radar in 2015.
Also reports 10 new 737 orders taken in over the past week.
American Capital Ltd. announces a big deal that would free up cash on its balance sheet and build on the value of its largest portfolio company, American Capital Asset Management.
A surprise buyout, MannKind's sanguine PDUFA update regarding Afrezza, and three positive clinical studies, mark this week's top biotech stories.
American Capital, it's time to come clean. Management should no longer have free reign to egregious stock-based compensation.
Will investors pay up for American Capital's prized asset management arm?
Main Street Capital is becoming a full-blown asset manager, following in the footsteps of larger rivals American Capital Ltd. and Ares Capital.
American Capital's since source of strength -- and largest source of operating income -- took a dive in the fourth quarter of 2013.
American Capital will report its most important quarter in years on February 10th. Here's why all eyes will be on this BDC.